16:55 EDT PTC Therapeutics (PTCT) trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- PTC Therapeutics announces FDA approval of Sephience for treatment of PKU
- PTC Therapeutics trading halted, news pending
- Citi ups PTC Therapeutics target, adds ‘upside catalyst watch’
- Cautious Outlook on PTC Therapeutics: Sepiapterin’s Limited Potential to Offset Declining DMD Revenues
- PTC Therapeutics Advances Long-Term Study on Vatiquinone for Friedreich Ataxia